Motivational Enhancement for Spanish Speaking Individuals - 1 - Full Text View

Motivational Enhancement for Spanish Speaking Individuals - 1

This study has been completed.

Sponsors and Collaborators:	National Institute on Drug Abuse (NIDA) Yale University
Information provided by:	National Institute on Drug Abuse (NIDA)
ClinicalTrials.gov Identifier:	NCT00078169

Purpose

The purpose of this study is to compare a three-session Spanish version of Motivational Enhancement Therapy (MET) to standard treatment to see how well MET engages and retains Spanish-speaking clients in outpatient substance abuse treatment.

Condition	Intervention	Phase
Substance-Related Disorders	Behavioral: Behavior Therapy	Phase III

U.S. FDA Resources

Study Type:	Interventional
Study Design:	Treatment

Official Title:	Motivational Enhancement for Spanish Speaking Individuals

Further study details as provided by National Institute on Drug Abuse (NIDA):

Primary Outcome Measures:

Treatment retention, drug and alcohol abstinence

Estimated Enrollment:	463
Study Start Date:	November 2003
Study Completion Date:	October 2005
Primary Completion Date:	October 2005 (Final data collection date for primary outcome measure)

Eligibility

Ages Eligible for Study:	18 Years and older
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

All subjects included unless medical/psychiatrically unstable

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00078169

Locations


United States, Colorado
	Island Grove RTC
	Greeley, Colorado, United States, 80631

United States, Florida
	Miami Behavioral Health
	Miami, Florida, United States, 33161

United States, New Mexico
	Counseling & Psychotherapy Institute
	Albuquerque, New Mexico, United States, 87194
	The Life Link
	Santa Fe, New Mexico, United States, 87505

United States, New York
	Narco Freedom (Bridge Plaza)
	Long Island City, New York, United States, 11101

United States, Oregon
	Changepoint, Inc.
	Portland, Oregon, United States, 97402
	Changepoint - Cedar Hills Blvd
	Portland, Oregon, United States, 97292

Sponsors and Collaborators

National Institute on Drug Abuse (NIDA)

Yale University

Investigators


Principal Investigator:	Kathleen Carroll, Ph.D.	Yale University

More Information

Study ID Numbers:	NIDA-CTN-0021-1
First Received:	February 19, 2004
Last Updated:	July 28, 2008
ClinicalTrials.gov Identifier:	NCT00078169
Health Authority:	United States: Federal Government

Study placed in the following topic categories:

Mental Disorders

Substance-Related Disorders

Disorders of Environmental Origin

ClinicalTrials.gov processed this record on November 30, 2008